Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M116,306Revenue $M139,367Net Margin (%)3.3Z-Score4.9
Enterprise Value $M126,751EPS $4.0Operating Margin %6.3F-Score6
P/E(ttm))26.0Cash Flow Per Share $4.1Pre-tax Margin (%)5.5Higher ROA y-yN
Price/Book3.110-y EBITDA Growth Rate %12.4Quick Ratio0.7Cash flow > EarningsY
Price/Sales0.95-y EBITDA Growth Rate %11.2Current Ratio1.4Lower Leverage y-yY
Price/Cash Flow11.4y-y EBITDA Growth Rate %7.9ROA % (ttm)6.4Higher Current Ratio y-yN
Dividend Yield %1.1Insider Buy (3m)0ROE % (ttm)12.2Less Shares Outstanding y-yY
Payout Ratio %28.0Shares Outstanding M1,125ROI % (ttm)8.1Gross Margin Increase y-yN

Gurus Latest Trades with CVS

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CVSRay Dalio 2014-12-31 Buy 0.04%$78.81 - $98.25
($88.16)
$ 103.3617%New holding, 55411 sh.55,411
CVSJoel Greenblatt 2014-12-31 Reduce$78.81 - $98.25
($88.32)
$ 103.3617%Reduce -44.87%5,154
CVSNWQ Managers 2014-12-31 Reduce-0.57%$78.81 - $98.25
($88.16)
$ 103.3617%Reduce -33.62%1,287,296
CVSChris Davis 2014-12-31 Sold Out -0.53%$78.81 - $98.25
($88.16)
$ 103.3617%Sold Out0
CVSRobert Olstein 2014-12-31 Reduce-0.18%$78.81 - $98.25
($88.16)
$ 103.3617%Reduce -18.48%75,000
CVSScott Black 2014-12-31 Reduce-0.18%$78.81 - $98.25
($88.16)
$ 103.3617%Reduce -13.03%108,124
CVSChris Davis 2014-09-30 Reduce-1.52%$76.11 - $82.24
($78.94)
$ 103.3631%Reduce -76.1%2,153,905
CVSNWQ Managers 2014-09-30 Reduce-0.14%$76.11 - $82.24
($78.94)
$ 103.3631%Reduce -8.48%1,939,169
CVSJoel Greenblatt 2014-09-30 Reduce-0.05%$76.11 - $82.24
($78.94)
$ 103.3631%Reduce -85.79%9,348
CVSTom Gayner 2014-06-30 Add0.22%$72.58 - $78.92
($75.58)
$ 103.3637%Add 105.21%197,000
CVSJoel Greenblatt 2014-06-30 Add0.05%$72.58 - $78.92
($75.58)
$ 103.3637%Add 763.24%65,796
CVSKen Fisher 2014-06-30 Add0.01%$72.58 - $78.92
($75.58)
$ 103.3637%Add 76.33%155,365
CVSChris Davis 2014-06-30 Reduce-0.51%$72.58 - $78.92
($75.58)
$ 103.3637%Reduce -21.19%9,012,151
CVSNWQ Managers 2014-06-30 Reduce-0.41%$72.58 - $78.92
($75.58)
$ 103.3637%Reduce -22.79%2,118,767
CVSScott Black 2014-06-30 Reduce-0.41%$72.58 - $78.92
($75.58)
$ 103.3637%Reduce -29.12%126,558
CVSRobert Olstein 2014-03-31 Buy 0.94%$65.44 - $75.3
($70.6)
$ 103.3646%New holding, 92000 sh.92,000
CVSPRIMECAP Management 2014-03-31 Add0.23%$65.44 - $75.3
($70.6)
$ 103.3646%Add 521.24%3,221,930
CVSTom Gayner 2014-03-31 Buy 0.22%$65.44 - $75.3
($70.6)
$ 103.3646%New holding, 96000 sh.96,000
CVSJoel Greenblatt 2014-03-31 Add$65.44 - $75.3
($70.6)
$ 103.3646%Add 77.75%7,622
CVSChris Davis 2014-03-31 Reduce-3.79%$65.44 - $75.3
($70.6)
$ 103.3646%Reduce -65.41%11,435,259
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CVS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CVS Ray Dalio 2014-12-3155,41100.04New Buy
CVS Tom Gayner 2014-12-31232,0000.020.59+6.42%
CVS Ken Fisher 2014-12-31142,0360.010.03+0.91%
CVS PRIMECAP Management 2014-12-313,186,9300.280.31-0.36%
CVS John Rogers 2014-12-3193,6750.010.1-1.68%
CVS James Barrow 2014-12-31352,9890.030.05-1.71%
CVS Mario Gabelli 2014-12-311,489,2630.130.75-2.54%
CVS Ruane Cunniff 2014-12-3124,95300.01-6.03%
CVS Vanguard Health Care Fund 2014-12-314,015,1360.350.91-8.5%
CVS Scott Black 2014-12-31108,1240.011.5-13.03%
CVS Robert Olstein 2014-12-3175,0000.010.88-18.48%
CVS NWQ Managers 2014-12-311,287,2960.111.5-33.62%
CVS Joel Greenblatt 2014-12-315,15400-44.87%
CVS Chris Davis 2014-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


CVS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Roberts Jonathan CEVP & President, CVS/caremark 2015-01-07Sell86,487$95.318.54view
MERLO LARRY JPresident and CEO 2015-01-05Sell144,144$94.39.7view
Lofberg Per GHEVP 2015-01-02Sell347,343$95.288.57view
Brennan Troyen AEVP, Chief Medical Officer 2015-01-02Sell50,240$95.718.09view
Sussman AndrewSVP & Pres, CVS/minuteclinic 2015-01-02Sell4,220$95.678.13view
Foulkes HelenaEVP, President-CVS/pharmacy 2014-11-07Sell46,325$88.0617.48view
Bisaccia LisaSVP, Chief HR Officer 2014-10-27Sell33,507$8521.71view
Sussman AndrewSVP & President, MinuteClinic 2014-09-02Sell9,020$79.4530.21view
Joyner J. DavidEVP, Sales & Account Services 2014-08-06Sell123,516$76.135.94view
Boratto Eva CSVP, Cont & Chief Acct Officer 2014-07-21Sell22,107$76.7734.75view

Press Releases about CVS :

    Quarterly/Annual Reports about CVS:

    News about CVS:

    Articles On GuruFocus.com
    Gabelli Growth Fund Q4 Commentary Feb 24 2015 
    Looking Ahead of Wall Street: Coca-Cola, PepsiCo, CVS Health Feb 09 2015 
    Gilead Sciences Offering Fresh Wave Of Competition To AbbVie’s Viekira Pak Feb 06 2015 
    Has Gilead Sciences Been Able To Maintain Its Lead Run In The Face Of Competition? Jan 22 2015 
    18 Cool Dividend Growth Large Caps For A Hot Market Jan 14 2015 
    Weekly Insider Sells Highlight: CVS, MNST, CAG, EVHC Jan 11 2015 
    Weekly CEO Sells Highlight: Six Flags Entertainment Corp, Gilead Sciences Inc, Ingersoll-Rand PLC, C Jan 10 2015 
    Oakmark Equity and Income Fund Fourth Quarter 2014 Commentary Jan 09 2015 
    Gilead Strikes Deal with CVS, Hits Back AbbVie Jan 06 2015 
    Why Ballard Power Systems Is a Smart Investment Dec 19 2014 


    More From Other Websites
    Final Glance: Drug Benefits companies Mar 03 2015
    Final Glance: Drugstore companies Mar 03 2015
    Final Glance: Drugstore companies Mar 03 2015
    Final Glance: Drug Benefits companies Mar 03 2015
    Cardinal Health Set to Buy Cordis, Shares Hit 52-Week High - Analyst Blog Mar 03 2015
    Midday Glance: Drugstore companies Mar 02 2015
    Midday Glance: Drugstore companies Mar 02 2015
    Midday Glance: Drug Benefits companies Mar 02 2015
    Midday Glance: Drug Benefits companies Mar 02 2015
    Early Glance: Drugstore companies Mar 02 2015
    Early Glance: Drugstore companies Mar 02 2015
    Early Glance: Drug Benefits companies Mar 02 2015
    Early Glance: Drug Benefits companies Mar 02 2015
    Campus Crest Communities Inc (CCG): Clinton Group Goes Activist; Check Out the Fund’s Other Top... Mar 02 2015
    CVS Health To Present At Barclays Global Healthcare Conference Feb 27 2015
    CVS Health To Present At Barclays Global Healthcare Conference Feb 27 2015
    Horizon Pharma Soars On Q4 Beat, Guidance Raise Feb 27 2015
    Catamaran EPS Tops, But Stock Falls On Weak Guidance Feb 26 2015
    Moody's Upgrades Three and Affirms Three Classes of FULB 1998-C2 Feb 26 2015
    Apple has Apple Pay hurdles to jump Feb 23 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK